Status:
COMPLETED
Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Addiction, Substance
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
The current containment linked to COVID-19 will have consequences for people suffering from addiction and there is a risk of overdoses when the containment ends. So the investigators hypothesize that ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- \>18 years
- Accept study
- live with an addiction
- Exclusion criteria:
- \- not being able to answer the questionnaire
Exclusion
Key Trial Info
Start Date :
April 8 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04343339
Start Date
April 8 2020
End Date
September 30 2020
Last Update
October 8 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295